M. Şerefettin CANDA, Merih GÜRAY, Ümit D. ACAR

The histopathologic and the immunohistochemical features of secretory meningiomas

PDF

___

1. Parisi JE, Mena H. Nonglial tumors. In: Principles and Practice of Neuropathology. St Louis: Mosby, 1993, pp: 203-213.
2. Kleihues P, Burger PC, Scheithauer BW. The new classification of brain tumors. Brain Pathol 3: 255-268, 1993.
3. Canda MÞ. MeningiomlarÝn genel patolojik zellikleri. Trk Neopl Derg 3 (2): 79-89, 1995.
4. Canda MÞ. MeningiomlarÝn patolojisi (Yeni yntemle 58 olgunun histopatolojik olarak sÝnÝflandÝrÝlmasÝ ve derecelendirilmesi). Trk Patol Derg 11 (2): 272-277, 1995.
5. Probst-Cousin S, Villagran-Lillo R, Lahl R, Bergmann M, Schmid KW, Gullotta F. Secretory meningioma: clinical, histologic, and immunohistochemical findings in 31 cases. Cancer 79: 2003- 2014, 1997.
6. Liebig T, Hoffmann T, Hosten N, Sander B, Van Landeghem F, Stoltenburg Didinger G, Lanksch WR. Lipomatous secretory meningioma: case report and review of the literature. Neuroradiol 40 (10): 656-8, 1998.
7. Tsuzuki N, Nakau H, Sugaya M, Hashizume K, Matsukuma S, Wada R, Kuwabara N. Secretory meningioma with severe perifocal edema-case report. Neurol Med Chir (Tokyo) 37 (8): 620-3, 1997.
8. Cushing H, Eisenhardt L. Meningiomas: their classification, regional behaviour, life history and surgical end results. Springfield, IL: Charles C Thomas, 1938.
9. Kepes JJ. Observations on the formation of psammoma bodies in meningiomas. J Neuropathol Exp Neurol 1961; 34: 282-9.
10. Alguacil-Garcia A, Pettigrew NM, Sima AAF. Secretory meningioma: a distinct subtype of meningioma. Am J Surg Pathol 10: 102-11, 1986.
11. Budka H. Hyaline inclusions (Pseudopsammoma bodies) in meningiomas: immunocytochemical demonstration of epithel-like secretion of secretory component and immunoglobulins A and M. Acta Neuropathol (Berl) 56 (4): 294-8, 1982.
12. Sav A, SylemezoÛlu F, zer F, Pamir N, Kll S, EkicioÛlu G. Secretory meningioma: a conventional histochemical study of six cases. Turk Neurosurg 2: 10-13, 1991.
13. Kamei Y, Watanabe M, Nakayama T. Prognostic significance of p53 and p21WAF1/CIP1 immunoreactivity and tumor micronecrosis for recurrence of meningiomas. J Neurooncol 46 (3): 205-13, 2000.